Ypsomed

History

Year	Detail
1984	Ypsomed established as Disetronic.
2003	Disetronic is renamed Ypsomed.
2005	Ypsomed founds its subsidiary In the Czech Republic.
2007	Ypsomed acquires various diabetes sales organisations.
2008	Ypsomed founds its subsidiary in India.
2009	The umbrella brand mylife Diabetescare is launched.
2011	Ypsomed acquires the infusion business Orbit from ICU Medical, U.S.
2012	The mylife DailyDose self-injection system is launched.
2013	The mylife Orbit Reservoir is launched.
2016	Ypsomed founds its subsidiary in Australia.
2017	The mylife YpsoPump insulin pump is launched in France, the Czech Republic, Switzerland, Italy.
2019	Ypsomed founds its subsidiary in the U.S..
2020	Ypsomed and Dexcom enter into partnership to drive closed loop system.
2023	Ypsomed partners with S3 Connected Health to expand its digital health offering.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI: Your Say